IMR Press / EJGO / Volume 19 / Issue 2 / pii/1998129

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with S.O.G.

Original Research

Aztreonam plus piperacillin - empiric treatment of neutropenic fever in gynecology-oncology patients receiving cisplatin-based chemotherapy

Show Less
1 Gynecologic Oncologic Unit, Meir Hospital, Sapir Medical Center, Kfar-Saba, Israel
2 Department of Ob.-Gyn., Meir Hospital - Sapir Medical Center, Kfar-Saba, Israel
3 Infectious Disease Unit, Meir Hospital - Sapir Medical Center, Kfar-Saba, Israel
Eur. J. Gynaecol. Oncol. 1998, 19(2), 126–129;
Published: 10 April 1998

Antibiotic therapy must be instituted promptly and on an empiric basis in neutropenic patients. We evaluated the efficacy of a combined antibiotic regimen of monobactam (aztreonam) and antipseudomonal penicillin (piperacillin) in treating neutropenic fever episodes in gynecologic-oncology patients receiving cisplatin-based chemotherapy. A retrospective analysis of response to this regimen was performed. The rationale of this combination is the lack of nephrotoxicity and ototoxicity in patients who are or were previously treated with other nephrotoxic/ototoxic agents like cisplatin. A total of 19 courses of this regimen was administered to 13 patients with neutropenic fever following a complete fever work-up. Aztreonam (l-2gr q8h) plus piperacillin (4gr q8h) were administered intravenously for 6-8 days. Blood cultures were positive in four febrile episodes, and urine cultures were positive in seven. Gram negative organisms accounted for all positive cultures. The cultured organism showed in-vitro sensitivity to at least one of the drugs in all positive isolates. Clinical response with defervescence was noted during therapy in 18/19 courses (94.7%). Although the two drugs share a common bactericidal mechanism they were found to be highly active in this subgroup of patients. A double blind prospective evaluation of this empiric combination is warranted.

Neutropenic feve
Back to top